Wenge Xing
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Hepatitis C virus research
- Virology top 10%
- HIV Research and Treatment
Papers in
- Hepatology 23
- Hepatocellular Carcinoma Treatment and Prognosis 15
- Hepatitis C virus research 8
- Virology 7
- HIV Research and Treatment 7
- Co-authors
- Haipeng Yu (14 shared papers)Changfu Liu (8 shared papers)Tongguo Si (5 shared papers)Xueling Yang (9 shared papers)Weihao Zhang (11 shared papers)Zhi Guo (6 shared papers)Yan Jiang (11 shared papers)Lu Wang (2 shared papers)
- Journals
- Journal of Clinical Oncology (4 papers)Cryobiology (4 papers)Frontiers in Immunology (3 papers)International Journal of Hyperthermia (2 papers)Journal of Medical Virology (2 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Wenge Xing
50 papers receiving 632 citations
Peers
Comparison fields: 5 of 64
- Hepatology 242
- Virology 61
- Infectious Diseases 81
- Cancer Research 56
- Pulmonary and Respiratory Medicine 111
Countries citing papers authored by Wenge Xing
This map shows the geographic impact of Wenge Xing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenge Xing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenge Xing more than expected).
Fields of papers citing papers by Wenge Xing
This network shows the impact of papers produced by Wenge Xing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenge Xing. The network helps show where Wenge Xing may publish in the future.
Co-authors
The 25 scholars most cited alongside Wenge Xing, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | [A sero-epidemiological study on hepatitis C in China]. | 2011 | 80 |
| 2 | 2020 | 70 | |
| 3 | 2021 | 51 | |
| 4 | 2021 | 46 | |
| 5 | 2023 | 31 | |
| 6 | 2013 | 28 | |
| 7 | 2017 | 28 | |
| 8 | 2017 | 23 | |
| 9 | 2010 | 22 | |
| 10 | 2009 | 21 | |
| 11 | 2021 | 20 | |
| 12 | 2022 | 18 | |
| 13 | 2011 | 18 | |
| 14 | 2020 | 14 | |
| 15 | 2011 | 13 | |
| 16 | 2019 | 13 | |
| 17 | 2018 | 13 | |
| 18 | 2012 | 11 | |
| 19 | 2009 | 10 | |
| 20 | 2022 | 10 |
About Wenge Xing
Wenge Xing is a scholar working on Hepatology, Virology, Pulmonary and Respiratory Medicine, Epidemiology and Oncology, having authored 54 papers that have together received 644 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (15 papers), Hepatitis C virus research (8 papers), HIV Research and Treatment (7 papers), Hepatitis B Virus Studies (4 papers), HIV/AIDS Research and Interventions (4 papers), HIV/AIDS drug development and treatment (4 papers), Ferroptosis and cancer prognosis (2 papers) and Renal cell carcinoma treatment (2 papers). The work is most often cited by research in Hepatology (242 citations), Virology (61 citations), Infectious Diseases (81 citations), Cancer Research (56 citations) and Pulmonary and Respiratory Medicine (111 citations). Wenge Xing has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Haipeng Yu, Changfu Liu, Tongguo Si, Xueling Yang, Weihao Zhang, Zhi Guo, Yan Jiang, Lu Wang, Junfeng Wang and Ti Zhang. Their work appears in journals such as Journal of Clinical Oncology, Cryobiology, Frontiers in Immunology, International Journal of Hyperthermia and Journal of Medical Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.